Entrada Therapeutics
TRDA5.8004.61% ( -0.280 )
Entrada Therapeutics (TRDA)
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines tha...
- Open
- 6.100
- High
- 6.110
- Low
- 5.780
- Prev. Close
- 6.080
- Volume
- 132.57K
- Turnover
- 782.33K
- Avg Price
- 5.901
- Bid/Ask Ratio
- --
- Amplitude
- 5.43%
- 52wk High
- 16.450
- Volume Ratio
- 0.52
- Turnover Ratio
- 0.56%
Entrada Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$18.75223.83%
Forecast & RatingStrong buy
8analysts
- Strong buy87.50%
- Buy0.00%
- Hold12.50%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 10 at 12:00 AM
Entrada Therapeutics (NASDAQ:TRDA) Trading 1.1% Higher - Still a Buy?
- benzinga_article · Jun 5 at 04:06 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- prnewswire · May 28 at 09:57 AM
10:54 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA
- Tip Ranks · May 19 at 05:48 AM
Entrada Therapeutics Highlights Transformational Year and Pipeline Progress
- TradingView · May 19 at 05:03 AM
Entrada Therapeutics updates corporate presentation, cites DMD Cohort 1 safety and functional gains; Cohort 2/45 data due 2026
- prnewswire · May 14 at 09:30 PM
22:30 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA
